Gabutan, Sharif P.

HRN: 23-47-10  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2023
CEFUROXIME 750MG (VIAL)
08/04/2023
08/11/2023
IV
280mg
Q8
PCAP C
Waiting Final Action 
08/05/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
08/05/2023
08/09/2023
PO
2.1ml
OD
PCAP-C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: